Indepth interview available now on www.cantos.com with Georges Jacobs, Chairman of the Executive Committee, UCB
* Strategy and fit
* Why Celltech?
* Financing and integration
and Dr Roch Doliveux, CEO, UCB Pharma
* CDP 870
* Why Celltech?
* Biotech v. pharma
* Competing in the US
* Integration
A video interview is also available with Dr Goran Ando, CEO, Celltech.
An on-demand webcast of the investor presentation will be available later today.